Orthofix Medical Inc. OFIX
Medical/Dental Instruments · IPO 1992 · data as of November 13, 2026
Orthofix Medical Inc. (OFIX) is a healthcare company listed in the US with a market value of about $292M. In the twelve months to September 30, 2026 it had revenue of $835M and net income of -$45M, a net margin of -5.4%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 15% a year, a 5-year average ROIC of -8%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 88% below the current price.
About Orthofix Medical
Orthofix Medical is listed in the US and classified in medical/dental instruments, IPO year 1992. Revenue went from $402M in 2014 to $822M in 2025, growth of about 6.7% a year. It was profitable in 4 of the last 10 years in our data. Its share count rose by 97% over three years (dilution for shareholders). It spends 8% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $835M | $822M | $799M | $747M | $461M | $464M | $407M | $460M | $453M | $434M | $410M |
| Net income | -$45M | -$92M | -$126M | -$151M | -$20M | -$38M | $3M | -$28M | $14M | $6M | $3M |
| Free cash flow | -$44M | -$1M | -$9M | -$106M | -$33M | $690000 | $59M | $13M | $36M | $24M | $43M |
| EPS (diluted) | $-1.11 | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 | $-1.51 | $0.72 | $0.34 | $0.17 |
| Net margin | -5.4% | -11.2% | -15.8% | -20.3% | -4.3% | -8.3% | 0.6% | -6.2% | 3.0% | 1.4% | 0.8% |
| ROIC | — | -10.1% | -9.9% | -15.4% | -3.0% | -1.9% | -1.4% | -4.5% | 5.1% | 10.9% | 6.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $10.00, 39% above the current price; targets range from $9.00 to $11.00; the consensus rating is “Buy”; expected EPS is $0.43 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Orthofix Medical stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 88% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Orthofix Medical pay a dividend?
Not currently.
Is Orthofix Medical a good stock to buy?
We do not give buy or sell advice. Orthofix Medical scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.